12]. Ceftaroline has been approved by FDA in 2010 and by European Medical Agency (EMA) in 2012 for the treatment of acute bacterial SSSIs and CAP. Ceftaroline was reported to have synergy when combined with amikacin, tazobactam
There is a free version, but it’s best to use our subscription version because you get a lot more information and it does things like fill out interlibrary loan forms for you. You must use the subscription version to answer any assignment questions. You can use Google Scholar. One of ...
There is a free version, but it’s best to use our subscription version because you get a lot more information and it does things like fill out interlibrary loan forms for you. You must use the subscription version to answer any assignment questions. You can use Google Scholar. One of ...
Download keyboard_arrow_down Browse Figures Versions Notes Abstract Worldwide, sepsis is a well-recognized cause of death. Acute kidney injury (AKI) may be related to sepsis in up to 70% of AKI cases. Sepsis-associated AKI (SA-AKI) is defined as the presence of AKI according to the ...